At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
Last month´s ESMO Congress: ecancerTV coverage of VHIO faculty who chaired, presented, delivered and discussed
Recently celebrated in Copenhagen, Denmark, 07-11 October 2016, the 2016 Congress of the European Society for Medical Oncology (ESMO), surpassed…
10 Nov 2016
Gene expression refines triple-negative breast cancer diagnosis
Researchers at the Vall d’Hebron Institute of Oncology (VHIO) and University of North Carolina have conducted a study on gene…
25 Feb 2013
Novel bispecific agent as mono or in combo with paired immunotherapy promises increased therapeutic efficacy against metastatic colorectal cancer
Novel bispecific antibody that simultaneously binds to the carcinoembryonic antigen (CEA) and lymphocytes triggers immune response in patients with metastatic…
05 Jun 2017
WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
17 Dec 2012
FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
Source: WIN Consortium VILLEJUIF, France–(BUSINESS WIRE)– WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start…
09 Aug 2017
VHIO´s Laura Soucek receives ICREA professorship to further spur research of excellence at International level
ICREA – the Catalan Institution for Research and Advanced Studies, founded in 2001 with the support of the Catalan Government,…
19 Jan 2015
Dr. José Baselga wins the "Physician of the Year” award from ABC Salud
The prize-giving ceremony was held on Thursday 7 April at the head office of the ABC newspaper in Madrid.
Dr. José Baselga, one of Spain’s most prestigious international oncologists and a key figure in the research and treatment of breast cancer, has been distinguished as “Physician of the Year”. This first edition of the ABC Health Awards recognises the outstanding work of medical professionals and institutions in the public and private health sectors.
11 Apr 2011
In partnership with leading organisations across the globe AECC declares 24 September as World Cancer Research Day
Today, a special roundtable, presided by Her Majesty Queen Letizia of Spain, President of the Spanish Association Against Cancer (AECC),…
22 Sep 2016
VHIO researchers discover that a subgroup of breast tumors constitutes a unique type of cancer by itself
Based on the genomic analysis of 6 tumor types, VHIO´s Translational Genomics Group has established that breast tumors of the…
19 Dec 2013
ICREA celebrates 15 years fortifying Catalonia-based research of excellence
ICREA – the Catalan Institution for Research and Advanced Studies, founded back in 2001 with the support of the Catalan…
29 Jun 2016
BIB launches portal to promote Catalan bioinformatics platform
Bioinformatics Barcelona (BIB), launched in 2014, constitutes a regionally-based multi-center bioinformatics platform as part of a joint initiative of the…
15 Jun 2016
PLoS One: Vitamin D Receptor Deficiency Enhances Wnt/ß-Catenin Signaling and Tumor Burden in Colon Cancer
CONFIRMATION THAT VITAMIN D ACTS AS A PROTECTIVE AGENT AGAINST THE ADVANCE OF COLON CANCER A study conducted by…
16 Aug 2011
Therapeutic targets in pancreatic cancer
Davide Melisi will offer a conference about TGF-ß signaling for anticancer therapies
07 Sep 2010
2016 independent nationwide evaluation ranks Vall d´Hebron´s Medical Oncology Department top of the leaderboard for third consecutive year
According to a third independent, annual benchmark evaluation of the Spanish healthcare sector, Monitor de Reputación Sanitaria (MRS), issued by…
14 Dec 2016
The promise of novel bispecific antibody for patients with heavily-pretreated metastatic colorectal cancer: VHIO´s Guillem Argilés discusses preliminary data showing efficacy and favorable safety profile
During a Selected Abstracts Session entitled New Drugs in GI Cancer and Abstracts on Non-Colorectal Cancer at the recent European…
11 Jul 2017
